Corteva Agriscience introduced Telbek PRO on January 20, 2026, marking the first time the company offers a Group‑21 fungicide in its cereal portfolio. The product combines the Adavelt™ active ingredient with a dual mode of action that covers both Group 3 and Group 21, giving growers a broad‑spectrum tool against Fusarium head blight, Septoria, stripe rust, tan spot, and glume blotch.
Telbek PRO’s dual‑mode chemistry delivers protection across the entire wheat growing season. The Group 3 component targets early‑season leaf diseases, while the Group 21 component provides late‑season control of Fusarium head blight and other head‑blight pathogens. Early field trials reported by Corteva indicate that the fungicide improves yield stability and produces cleaner grain, supporting the company’s claim of a high‑value solution for Canadian farmers facing rising disease pressure.
The launch is part of Corteva’s broader strategy to deliver differentiated, high‑margin crop‑protection solutions that drive farmer confidence and return on investment. “Telbek PRO expands our cereal portfolio and establishes a new benchmark for yield protection and return on investment in Canadian wheat,” said Loralee Orr, Canadian Vice President of Commercial. The addition of a Group‑21 mode of action strengthens the company’s competitive stance in a market where resistance management and broad‑spectrum coverage are critical.
Telbek PRO is now available through Corteva representatives across Canada and is slated for use in the 2026 planting season. The product’s distribution plan aligns with the company’s existing sales network, ensuring that growers can access the fungicide without delay as they prepare for the upcoming crop cycle.
By adding a Group‑21 fungicide, Corteva not only expands its disease‑control options but also positions itself to meet the growing demand for resistance‑management solutions. The launch underscores the company’s commitment to innovation in wheat protection and reinforces its leadership in the Canadian crop‑protection market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.